Autonomic Nervous System: Cholinergic and Adrenergic Agents Flashcards

1
Q

Mecamylamine

A

A ganglionic blocking drug of both parasympathetic and sympathetic (Nn) receptors.

Used as an antihypertensive drug (peripheral vasodilator) and tobacco smoking cessation (blocks Nn receptors in reward center of brain).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the rate-limiting step of Ach synthesis?

A

The transport of choline into the pre-synaptic nerve endings by Na+-choline co-transporter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Steps of Ach synthesis

A
  1. Choline transported into pre-synaptic nerve endings by Na+-choline co-transporter
  2. Choline + Acetyl CoA–> Ach by a cytosolic choline acetyltransferase (ChAT)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Ach storage

A

In the nerve terminal vesicles

Active vesicular uptake by a H-Ach antiporter, Ach is ion trapped (+charged) in the vesicle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Ach Release

A

AP–> Ca influx –> docking of vesicle with plasma membrane –> release of Ach by exocytosis – Ach is always charged and therefore can’t cross membranes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Presynaptic Inhibition of Cholinergic Transmission is done by _______.

A

Botulinum toxin (deadly nightshade) - prevents the release of Ach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Hemicholinium

A

Prevents choline from entering the pre-synaptic nerve ending

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Vesamicol

A

Prevents the storage of Ach into vesicles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

onabotulinumtoxinA (Botox)

Mechanism

A

PRE SYNAPTIC DRUG

Mechanism: inactivates SNAP-25 required for docking of the vesicle with the presynaptic membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

onabotulinumtoxin A (Theraputic uses)

A
  1. Muscle spasms/dystonias (strabismus aka lazy eye–inject into dominant eye), blepharospasm (eyelid muscle spasm that shuts eyelids)
  2. Cosmetic - reduce glabellar, forehead, and lateral canthus lines, given IM
  3. Axillary hyperhidrosis (prevent sweating) - intradermal
  4. Chronic migraines, IM
  5. Overactive bladder disorder, intra-detrusor muscle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Onabotulinumtoxin A (side effects)

A
  1. Dysphagia and breathing difficulties (boxed warning) - from distant spread beyond injection site
  2. Muscle weakness (ptosis), urinary retention, pain
  3. Allergic reaction (due to it being a protein coming from a foreign bacteria)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Onabotulinumtoxin A (drug action)

A

Drug action: flaccid paralysis of skeletal muscle softens facial wrinkles and relaxes muscle spasms; inactivates sweat glands

Restoration of function requires sprouting of new nerve terminals; duration 3-4 months (irreversible inactivation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Cholinergic Receptor Subtypes

A

Muscarinic: GPCRs
Nictonic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

M3

A

(Smooth muscle, gland, endothelium)
Mediates excitation/contraction/secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

M2

A

(heart) - Gi –> signals cellular inhibition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Muscarine

A

PRE-SYNAPTIC DRUG

Prototype AGonist of Botulin Toxin; activates all M subtypes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Atropine

A

PRE SYNAPTIC DRUG

Prototype ANTAGonist of Botulism Toxin: blocks M subtypes

Sits on receptor to block but activates opposing response due to blocking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Nicotinic Receptors

A

Ligated ion channels with a fast response time

Stimulation increases permeability to Na+ causing membrane depolarization; persistent stimulation causes destimulation of receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Nn

A
  • neuronal (ganglia, adrenal medulla-Epi)
  • high-affinity agonist - Nicotine (stimulation followed by desensitization)
  • Prototype antagonist - Mecamylamine (anti-hypertensive agent)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Nm

A

-musculoskeletal; NMJ
- low-affinity agonist - Nicotine (stimulating –> densensitized –> skeletal muscle paralysis)
-prototype antagonist - d-tubocurarine (produces non-depolarizing (competitive) neuromuscular blockade

21
Q

Nicotine

A

PRE SYNAPTIC DRUG

High affinity agonist to Nn, low affinity agonist to Nm

Can look like an antagonist due to how tightly it binds

22
Q

d-tubocurarine

A

PRE SYNAPTIC DRUG

A prototype ANTAGonist for Nm that produces a depolarizing (competitive) neuromuscular blockade

23
Q

Acetylcholinesterase (AChE)

A

rapidly terminates cholinergic NT by hydrolysis of ACh

24
Q

Butyrylcholinesterase (BuChE)

A

expressed mainly in the plasma and liver. Is a drug-metabolizing enzyme of choline ester drugs (ACh). – only does Ach when injected –

25
Q

Steps for synthesis of Catecholamines - DA, NE, Epi

A

Tyrosine –(Tyrosine hydroxylase)–> Dopa – (LAAAD)–> Dopamine –(Dopamine beta hydroxylase) –> NE –(PNMT)–> Epi

Tyrosine –> Dopa is the rate-limiting step

26
Q

CNS basal ganglia and renal vasculature release…

A

Dopamine

27
Q

Adrenergic neurons release…

A

Norepinephrine

28
Q

Adrenal medulla releases…

A

Epinephrine because it has all four converting enzymes to convert NEpi–> Epi

29
Q

The release of cortisol in the cortex stimulates ______ and ______ release in the adrenal medulla.

A

Epi and NE

30
Q

Monoamine oxidase (MAO)

A
  • Degrades any catecholamine molecule that isn’t stored
  • In sympathetic nerve terminals, liver, and brain
  • ## Two isoforms: A , B; degrade tyramine (A), and histamine (B)
31
Q

Vesicular Monoamine Transporter (VMAT-2)

A

Actively transports catecholamines into vesicles – which are then passively diffused out of the storage vesicles

32
Q

Reserpine (Mechanism)

A

Inhibits VMAT-2 thus depleting catecholamines from being stored in vesicles and reduces CNS sympathetic outflow (Dopamine)

33
Q

Reserpine (therapeutic use)

A

Used as an old hypertensive: caused sedation, psychotic depression, and orthostatic hypotension

34
Q

Release of catecholamines

A

Same process as with cholinergic neurons (AP, Ca2+ influx, exocytosis)

35
Q

alpha-2 auto-receptors

A

Stimulation causes negative feedback inhibition of NE release – Gi inhibition of Ca2+ influx

36
Q

Antagonists of alpha-2 auto-receptors do what

A

Increase NE release

37
Q

Tyramine

A

PRE SYNAPTIC DRUG

Toxic amino acid in food (aged cheese, beer/wine, cured meat) that stimulates NE release – can cause hypertensive crisis by increasing sympathetic nerve terminal activity at heart and vasculature

38
Q

Tyramine (Mechanism)

A

Displaces NE from storage vesicles; elevated cytosolic NE triggers non-vesicular release by reverse transport through NET

39
Q

(Norepinephrine Transporter) NET

A

An intra-membranous transporter that can transport NE in either direction

40
Q

Why would a patient be at risk if they are on an MAOI (Monoamine Oxidase Inhibitor) and they consume Tyramine?

A

MAO degrades unstored NE and a MAOI will inhibit MAO from degrading free NE. Since tyramine displaces NE from storage vesicles, without MAO, NE will cause a hypertensive crisis. — therefore patient’s on MAOIs must have dietary restrictions

41
Q

Methyldopa (Therapeutic)

A

Gestational hypertension (safe for developing fetus) – side effects are dry mouth, edema, elevated risk of autoimmune hemolytic anemia (+Coombs’ test) with long-term use

42
Q

Methyldopa (Mechanism)

A

PRE SYNAPTIC DRUG

Alpha-2 agonist prodrug converted by DOPA decarboxylase –> methyl-dopamine and then by dopamine beta-hydroxylase –> methyl-NE (active form). - Methyl-NE binds to alpha-2 to halt release of NE.

Inhibits NE release and thus lowers blood pressure by decreasing sympathetic outflow from CNS to the heart, vasculature, and kidneys

43
Q

Adrenergic Receptor Subtypes

A

All coupled to G-proteins (GPCRs)

Pre-synaptic:
alpha 2 - Gi: decrease cAMP, M2 receptor in heart to slow HR

Postsynaptic:
alpha 1 - Gq: M3 receptor for vasoconstriction
beta 1 - Gs: increases cAMP; excitatory/contraction
beta 2 - Gs: relaxation of smooth muscle
beta 3 - Gs: relaxation of smooth muscle, lipolysis

44
Q

Cocaine

A

-PRE-SYNAPTIC DRUG
blocks reuptake of NE from NET.
- a local anesthetic for pain similar to lidocaine, novocaine etc. – but only one to block reuptake of NE – thus NE continuously fires in NMJ

45
Q

What are MAOIs used for therapeutically?

A

Depression and Parkinson’s disease

46
Q

Catechol-O-methyltansferase (COMT)

A
  • In the liver and kidney
  • Methylates and clears catecholamines (metabolism)
  • COMT inhibitors are used for Parkinson’s disease
47
Q

Both MAO and COMT do what?

A

They both metabolize NE and result in the production of VMA

48
Q

VMA

A
  • End results from metabolism of NE by COMT and MAO.
  • Major metabolite excreted in the urine; basis of clinical tests for pheochromocytoma (tumor of the adrenal medulla)
  • elevated in a hypertensive crisis when sympathetic nervous system is over activated
49
Q

Cholinergic Agonists and Antagonists

A

Agonists: “A big python came”
Acetylcholine (prototype)
- Bethanechol, pilocarpine, cevimeline

Antagonists: “And snuck by two Irish toddlers”
Atropine (prototype)
- scopolamine, ipratropium bromide, tolterodine, tropicamide